ClinConnect ClinConnect Logo
Search / Trial NCT05492149

Pulmonary Rehabilitation for COPD Patients: Can Performance Predict Exacerbation?

Launched by GROUPE HOSPITALIER DU HAVRE · Aug 5, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how physical performance during pulmonary rehabilitation can help predict worsening symptoms (called exacerbations) in patients with Chronic Obstructive Pulmonary Disease (COPD). The goal of pulmonary rehabilitation is to improve patients' ability to exercise and make breathing easier. Researchers believe that if a patient's ability to exercise decreases during rehabilitation, it might indicate that they are at risk of experiencing a worsening of their condition soon.

To participate in this trial, you must be an adult diagnosed with COPD and have completed at least five sessions of the pulmonary rehabilitation program. However, you won't be eligible if you've had a recent worsening of your COPD symptoms within the last month or if you've experienced any serious health issues that prevent you from continuing rehabilitation. If you join the study, you can expect to undergo regular physical exercises while being monitored to see how well you are doing. This trial aims to help improve the care and management of COPD by finding better ways to predict and prevent exacerbations.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult patients
  • COPD patients
  • Exclusion Criteria:
  • Patients who not performed not at least 5 sessions of the pulmonary rehabilitation program
  • Occurence of an adverse event that prevents further rehabilitation
  • Exacerbation in the previous month

About Groupe Hospitalier Du Havre

Groupe Hospitalier du Havre is a prominent healthcare institution in France, dedicated to providing comprehensive medical services and fostering innovative research in clinical care. With a commitment to enhancing patient outcomes, the group actively engages in clinical trials across various therapeutic areas, collaborating with multidisciplinary teams to advance medical knowledge and treatment options. Their state-of-the-art facilities and experienced professionals enable them to conduct rigorous and ethical research, contributing to the global medical community while ensuring the highest standards of patient safety and care.

Locations

Montivilliers, Groupe Hospitalier Du Havre, France

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials